Patents by Inventor John Harvey

John Harvey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10482388
    Abstract: Methods and apparatus of quantum information processing using quantum dots are provided. Electrons from a 2DEG are confined to the quantum dots and subjected to a magnetic field having a component directed parallel to the interface. Due to interfacial asymmetries, there is created an effective magnetic field that perturbs the energies of the spin states via an interfacial spin-orbit (SO) interaction. This SO interaction is utilized to controllably produce rotations of the electronic spin state, such as X-rotations of the electronic spin state in a double quantum dot (DQD) singlet-triplet (ST) qubit. The desired state rotations are controlled solely by the use of electrical pulses.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: November 19, 2019
    Assignee: National Technology & Engineering Solutions of Sandia, LLC
    Inventors: Ryan Michael Jock, Martin Rudolph, Andrew David Baczewski, Wayne Witzel, Malcom S. Carroll, Patrick Harvey-Collard, John King Gamble, IV, Noah Tobias Jacobson, Andrew Mounce, Daniel Robert Ward
  • Publication number: 20190337910
    Abstract: The present disclosure relates to compounds of formula (I) that are useful as modulators of ?7 nAChR, compositions comprising such compounds, and the use of such compounds for preventing, treating, or ameliorating disease, particularly disorders of the central nervous system such as cognitive impairments in Alzheimer's disease, Parkinson's disease, and schizophrenia, as well as for L-DOPA induced-dyskinesia and inflammation.
    Type: Application
    Filed: March 20, 2017
    Publication date: November 7, 2019
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: BRENDAN M. CROWLEY, BRIAN T. CAMPBELL, JOSEPH L. DUFFY, THOMAS J. GRESHOCK, DEODIAL G. GUIADEEN, ANDREW JOHN HARVEY, BELINDA C. HUFF, KENNETH J. LEAVITT, VANESSA L. RADA, JOHN M. SANDERS, WILLIAM D. SHIPE, LINDA M. SUEN, IAN M. BELL
  • Patent number: 10463711
    Abstract: Nutritive polypeptides are provided herein. Also provided are various other embodiments including nucleic acids encoding the polypeptides, recombinant microorganisms that make the polypeptides, vectors for expressing the polypeptides, methods of making the polypeptides using recombinant microorganisms, compositions and formulations that comprise the polypeptides, and methods of using the polypeptides, compositions and formulations.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: November 5, 2019
    Assignee: Axcella Health Inc.
    Inventors: Michael Hamill, Brett Boghigian, Caitlyn Harvey, David Berry, David Young, Geoffrey Von Maltzahn, John Kramarczyk, Jameson Rogers, Kathryn Heard, Michael Doherty, Nathaniel Silver, Phillip Samayoa, Subhayu Basu, Shaila Rahman, Vimal Vaidya, Ying-Ja Chen
  • Publication number: 20190307939
    Abstract: A gravity fed peritoneal dialysis (“PD”) machine includes: a frame configured to be set on a supporting surface; at least one load cell; a scale platform supported by the frame via the at least one load cell positioned between the frame and the scale platform; a drain container support in mechanical communication with and extending downwardly from the scale platform, the machine configured such that when the frame is set on the supporting surface, at least one fresh PD fluid supply container is supportable by the scale platform above the at least one load cell and at least one used PD fluid drain container is supportable by the drain container support below the at least one load cell, so that a combined weight of fresh PD fluid and used PD fluid may be sensed by the at least one load cell.
    Type: Application
    Filed: April 5, 2018
    Publication date: October 10, 2019
    Inventors: Ying-Cheng Lo, Aaron W. Brown, Yuanpang Samuel Ding, Alex Lao, Zachariah Louis Fuller, Aaron Joseph Geier, Alan John Harvey, Leansu Kiatoukaysy Lo
  • Publication number: 20190308945
    Abstract: The present disclosure relates to compounds of formula (I) that are useful as modulators of ?7 nAChR, compositions comprising such compounds, and the use of such compounds for preventing, treating, or ameliorating disease, particularly disorders of the central nervous system such as cognitive impairments in Alzheimer's disease, Parkinson's disease, and schizophrenia, as well as for L-DOPA induced-dyskinesia and inflammation.
    Type: Application
    Filed: October 30, 2017
    Publication date: October 10, 2019
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: BRENDAN M. CROWLEY, IAN M. BELL, ANDREW JOHN HARVEY, WILLIAM D. SHIPE, KENNETH J. LEAVITT, JOHN M. SANDERS, DEODIAL GUY GUIADEEN, LINDA M. SUEN, THOMAS J. GRESHOCK, VANESSA L. RADA
  • Publication number: 20190300507
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, I or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures where the definitions of the variables are provided herein.
    Type: Application
    Filed: November 3, 2017
    Publication date: October 3, 2019
    Applicant: AMGEN INC.
    Inventors: Yinhong CHEN, Alan C. CHENG, Mikkel V. DEBENEDETTO, Paul John DRANSFIELD, James S. HARVEY, Jonathan HOUZE, Aarif Yusuf KHAKOO, Su-Jen LAI, Zhihua MA, Vatee PATTAROPONG, Gayathri SWAMINATH, Charles KREIMAN, David C. MOEBIUS, Ankit SHARMA
  • Publication number: 20190290647
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: (I), (II) where the definitions of the variables are provided herein.
    Type: Application
    Filed: November 3, 2017
    Publication date: September 26, 2019
    Applicant: AMGEN INC.
    Inventors: Yinhong CHEN, Mikkel V. DEBENEDETTO, Paul John DRANSFIELD, James S. HARVEY, Jonathan HOUZE, Aarif Yusuf KHAKOO, Su-Jen LAI, Zhihua MA, Nobuko NISHIMURA, Vatee PATTAROPONG, Gayathri SWAMINATH, Wen-Chen YEH, Philip Dean RAMSDEN, Ankit SHARMA
  • Publication number: 20190290648
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: (I) (II) where the definitions of the variables are provided herein.
    Type: Application
    Filed: November 3, 2017
    Publication date: September 26, 2019
    Applicant: AMGEN INC.
    Inventors: Yinhong CHEN, Paul John DRANSFIELD, James S. HARVEY, Julie Anne HEATH, Jonathan HOUZE, Aarif Yusuf KHAKOO, David J. KOPECKY, Su-Jen LAI, Zhihua MA, Nobuko NISHIMURA, Vatee PATTAROPONG, Gayathri SWAMINATH, Wen-Chen YEH, Philip Dean RAMSDEN
  • Publication number: 20190284173
    Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: (I), (II) where the definitions of the variables are provided herein.
    Type: Application
    Filed: November 3, 2017
    Publication date: September 19, 2019
    Applicant: AMGEN INC.
    Inventors: Ning CHEN, Yinhong CHEN, Mikkel V. DEBENEDETTO, Paul John DRANSFIELD, James S. HARVEY, Julie Anne HEATH, Jonathan HOUZE, Aarif Yusuf KHAKOO, Su-Jen LAI, Zhihua MA, Nobuko NISHIMURA, Vatee PATTAROPONG, Gayathri SWAMINATH, Wen-Chen YEH, Charles KREIMAN
  • Publication number: 20190275008
    Abstract: Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula (I) and Formula (II) have the following structures: (I); (II). Intermediates (V) are also claimed.
    Type: Application
    Filed: November 3, 2017
    Publication date: September 12, 2019
    Applicant: AMGEN INC.
    Inventors: Matthew BROWN, Ning CHEN, Xiaoqi CHEN, Yinhong CHEN, Alan C. CHENG, Richard V. CONNORS, Jeffrey DEIGNAN, Paul John DRANSFIELD, Xiaohui DU, Zice FU, James S. HARVEY, Julie Anne HEATH, Lars V. HEUMANN, Jonathan HOUZE, Frank KAYSER, Aarif Yusuf KHAKOO, David j. KOPECKY, Su-Jen LAI, Zhihua MA, Julio C. MEDINA, Jeffrey T. MIHALIC, Steven H. OLSON, Vatee PATTAROPONG, Gayathri SWAMINATH, Xiaodong WANG, Malgorzata WANSKA, Wen-Chen YEH
  • Patent number: 10386280
    Abstract: A device for measuring shear properties of asphalt mixtures includes a machine for testing the material strength, equipped with an operational frame, fixing elements and driving mechanism, the machine including a steel socket equipped at at least one of a bottom and a top edge thereof with an inner flange to accommodate a testing specimen, the testing specimen having a central open hole, and a steel insert adapted to be inserted into the open hole in the testing specimen, the steel insert being equipped with a rim at at least one of an end thereof at the top edge of the steel socket and at end thereof at the bottom of the steel socket, while a size of a clearance between the inner flange and the rim being between 5 to 60 mm, and the steel insert being equipped with elements for fixing to clamping elements of the device, and measuring probes being connected to the steel insert.
    Type: Grant
    Filed: June 21, 2016
    Date of Patent: August 20, 2019
    Assignees: CZECH TECHNICAL UNIVERSITY IN PRAGUE, FACULTY OF CIVIL ENGINEERING, DEPARTMENT OF ROAD STRUCTURES, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Josef Zak, John Harvey, James Signore
  • Patent number: 10380335
    Abstract: In various example embodiments disclosed herein, a Dynamic Security Architecture Environment (DSAE) security architecture is provided in an externally connectable endpoint device (the security device), which can be connected to an existing host endpoint device, such as a computer, laptop, tablet, phone, vehicle, medical device, Industrial Control System (ICS), or other electronic or Internet connected device. The example embodiments can implement the DSAE security architecture in the security device that connects to a host endpoint device to make the host endpoint device more secure by enabling the security device to combat cyber attacks targeted toward the host device. The example embodiments described herein also provide details for creating a security device that leverages the DSAE architecture, wherein the security device is configured to connect via a wired or wireless medium for data communication with a host endpoint device to make the host device more secure.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: August 13, 2019
    Assignee: Security Together Corporation
    Inventors: Anthony Joseph Vargas, Kenneth Tallo, Andrew George Harvey, David Brian Petree, Thomas John Newman
  • Publication number: 20190225555
    Abstract: A composition including a liquid microbial mixture and a gemstone elixir. The composition is applied to soil of a plant to increase the health of the plant.
    Type: Application
    Filed: January 24, 2019
    Publication date: July 25, 2019
    Inventor: John Harvey Easterling
  • Patent number: 10294980
    Abstract: A quick connect and disconnect arrangement for a cable comprises a housing for holding the cable. The housing comprises a first section and a second section. One of the first section and the second section comprises a protruding lug having an aperture therein and the other of the first section and the second section comprises a locking system. The locking system comprises a channel, an opening disposed along a portion of the channel and for receiving the lug, and a bolt configured to move within the channel. When, in use, the housing is closed around the cable, the lug is positioned in the opening, the channel is aligned with the aperture and the bolt is configured to move within the channel in order to engage with the aperture and thereby retain the lug in the opening.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: May 21, 2019
    Assignee: GOODRICH ACTUATION SYSTEMS LIMITED
    Inventors: James Holding, Scott Haldron, John Harvey
  • Patent number: 10266529
    Abstract: The present invention provides crystalline Forms FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and related methods of treating and/or preventing a disease, such as a central nervous system disease (e.g., an anxiety disorder), using a crystalline Form FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and/or pharmaceutical compositions thereof.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: April 23, 2019
    Assignees: Bionomics Limited, Ironwood Pharmaceuticals, Inc.
    Inventors: Bernard Luke Flynn, Dharam Paul, Andrew John Harvey, Vasu V. Sethuraman, Raymond E. Forslund, Song Xue, Rob Livingston, Ahmad Hashash
  • Patent number: 10158898
    Abstract: Aspects of the disclosure relate to personalized options for consumption of content assets. In one aspect, the personalized options can be supplied (e.g., transmitted) asynchronously and can be indicative of information associated with a media asset of likely interest to an end user. In another aspect, the personalized options can permit administration of the content assets, such as automated generation of storage configuration(s) and/or playback configuration(s), based at least on consumption behavior of an end-user.
    Type: Grant
    Filed: July 26, 2012
    Date of Patent: December 18, 2018
    Assignee: Comcast Cable Communications, LLC
    Inventors: John Harvey, Michael Mattozzi, Matthew Hawthorne, Jeremy Volkman
  • Patent number: 10131786
    Abstract: A method of synthesizing copolymers is provided. The method can include coupling a degradable polymer to a poly(amino acid) and then deprotecting the copolymer if the poly(amino acid) contains protected side chains. Copolymer compositions are provided. These compositions include PLGA-PLL copolymers, PLGA-PLL-cbz copolymers, and copolymers of a polyester with a carboxylic acid end group coupled to a poly(amino acid) with an amine group. The compositions may include therapeutic blends and formulations of copolymers.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: November 20, 2018
    Assignees: INVIVO THERAPEUTICS CORPORATION, MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: John Harvey, Daniel Siegwart, Heng Lian Huang, Brian Hess, Alex Aimetti
  • Patent number: D852416
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: June 25, 2019
    Assignee: Dyson Technology Limited
    Inventors: Robert Mark Brett Coulton, Daniel John Thompson, Christopher Daniel Currer Wilkinson, Andrea Ee-Va Lim, Peter David Gammack, Stephen Benjamin Courtney, Alexander Stuart Knox, Jeremy Adam Tomas Ellis-Gray, Nicholas Giles Wilkins, Jonathan James Harvey Heffer, Annmarie Rita Nicolson, Emma Victoria Carson, Weiyi Chia, Wei Jie Lam
  • Patent number: D853642
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: July 9, 2019
    Assignee: Dyson Technology Limited
    Inventors: Robert Mark Brett Coulton, Daniel John Thompson, Christopher Daniel Currer Wilkinson, Andrea Ee-Va Lim, Peter David Gammack, Stephen Benjamin Courtney, Alexander Stuart Knox, Jeremy Adam Tomas Ellis-Gray, Jonathan James Harvey Heffer, Annmarie Rita Nicolson, Nicholas Giles Wilkins
  • Patent number: D855252
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: July 30, 2019
    Assignee: Dyson Technology Limited
    Inventors: Robert Mark Brett Coulton, Daniel John Thompson, Christopher Daniel Currer Wilkinson, Andrea Ee-Va Lim, Peter David Gammack, Stephen Benjamin Courtney, Alexander Stuart Knox, Jeremy Adam Tomas Ellis-Gray, Jonathan James Harvey Heffer, Annmarie Rita Nicolson, Nicholas Giles Wilkins